Lucence, Waseda University partner on liquid biopsy test

2017 09 14 23 05 1167 Cancer Cell 400

Lucence and Waseda University in Japan will develop a liquid biopsy laser-based imaging platform for early cancer detection. The technology captures thousands of high-resolution individual images of circulating tumor cells and clusters from a blood sample.

Lucence believes the technology could be used in potential applications in early cancer detection and disease monitoring. Lucence plans to commercialize the liquid biopsy platform from its CLIA-licensed laboratory in Palo Alto.

Page 1 of 4
Next Page